Quanticate bolsters PV service platform
Quanticate is bolstering its pharmacovigilance services with a recent addition to its risk management platform.
Quanticate is bolstering its pharmacovigilance services with a recent addition to its risk management platform.
Guest Column
The practice of incorporating the voice of the patient into clinical development has gained significant traction over the past decade, and rightfully so.
With offices in Philadelphia and Boston, Vynamic’s London office – co-located with STEM Healthcare – is the company’s first outside the US as it looks to support existing and new clients globally.
UPDATE
European generics industry faces opposition while pushing for the SPC manufacturing waiver to be altered so it allows for the production of drugs under patent for non-EU countries.
Studies are underway as the provider of genetically engineered rodent model solutions completes its most recent trip to the International Space Station.
The industry group recently announced its first technology standard, which addresses operational data exchange in an aim to improve information sharing between sponsors and CROs.
Amneal received approval of a generic of the Exelon patch, a complex generic transdermal drug delivery system, and plans to commercialize the product.